Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives

CK Chan, G Aimagambetova, T Ukybassova… - Journal of …, 2019 - Wiley Online Library
Viral infections contribute as a cause of 15–20% of all human cancers. Infection by
oncogenic viruses can promote different stages of carcinogenesis. Among many types of …

[HTML][HTML] 2020 list of human papillomavirus assays suitable for primary cervical cancer screening

M Arbyn, M Simon, E Peeters, L Xu, CJLM Meijer… - Clinical Microbiology …, 2021 - Elsevier
Background Only clinically validated HPV assays can be accepted in cervical cancer
screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 …

Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing

AC Chrysostomou, DC Stylianou, A Constantinidou… - Viruses, 2018 - mdpi.com
Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

[HTML][HTML] Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test

TC Wright, MH Stoler, CM Behrens, A Sharma… - Gynecologic …, 2015 - Elsevier
Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication

European Colorectal Cancer Screening … - …, 2013 - thieme-connect.com
Population-based screening for early detection and treatment of colorectal cancer (CRC)
and precursor lesions, using evidence-based methods, can be effective in populations with …

Triage of HPV positive women in cervical cancer screening

N Wentzensen, M Schiffman, T Palmer… - Journal of Clinical …, 2016 - Elsevier
Despite HPV vaccines, screening will remain central for decades to control cervical cancer.
Recently, HPV testing alone or with cytology was introduced as an alternative to cytology …

Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report

P Basu, A Ponti, A Anttila, G Ronco… - … journal of cancer, 2018 - Wiley Online Library
The second report on the implementation status of cancer screening in European Union
(EU) was published in 2017. The report described the implementation status, protocols and …

CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs

L Zhang, I Mosquera, E Lucas, ML Rol, AL Carvalho… - Nature medicine, 2023 - nature.com
The CanScreen5 project is a global cancer screening data repository that aims to report the
status and performance of breast, cervical and colorectal cancer screening programs using …

Cytology versus HPV testing for cervical cancer screening in the general population

G Koliopoulos, VN Nyaga, N Santesso… - Cochrane database …, 2017 - cochranelibrary.com
Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

[HTML][HTML] Cervical cancer screening guidelines and screening practices in 11 countries: a systematic literature review

W Wang, E Arca, A Sinha, K Hartl, N Houwing… - Preventive medicine …, 2022 - Elsevier
Abstract The World Health Organization (WHO) advocates population-based screening
programs to reduce the global incidence of cervical cancer. However, screening guidelines …